CoChat

Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer

Open access
Park, Byung Kyu, Koh, Hee Dong, Won, Sun Young, Cho, Yong Suk, Seo, Jeong Hun, An, Chansik, Park, Sumi · 2023 · Journal of Gastrointestinal Oncology

The DOI matches its Crossref record; 41 of the 46 references it cites were found in a registry or an index; 12 of the 47 sources its claims cite were checked for support.

Abstract

Prediagnostic CT findings suggestive of pancreatic cancer in scans obtained for unrelated reasons.

Overview

CoChat Summary

## TL;DR

This retrospective single-center study reviewed contrast-enhanced CT scans done within 1 year before pancreatic cancer diagnosis and found that 14 of 27 patients (51.9%) had suspicious findings that were overlooked. The main prediagnostic clues were a hypoattenuating mass, focal pancreatic duct dilatation, and distal parenchymal atrophy.

## Key findings

  • Among 27 patients, 7 (33.3%) had normal pancreatic parenchyma and duct findings, while 20 (74.1%) had abnormal findings on retrospective review.
  • Suspicious prediagnostic CT findings were seen in 14 patients (51.9%); these were all overlooked at the time of imaging.
  • The most common suspicious findings were hypoattenuating mass-like lesions in 9 patients, focal pancreatic duct dilatation in 6, and distal parenchymal atrophy in 2; 3 patients had two findings simultaneously.
  • The nine mass-like lesions had a median size of 1.2 cm, and the median time from CT to pancreatic cancer diagnosis was 6.6 months.

## Methods

  • Retrospective study of patients diagnosed with pancreatic cancer at one hospital between January 2008 and December 2019; 27 patients who had contrast-enhanced abdominal or chest CT including the pancreas within 1 year before diagnosis and had no reported suspected pancreatic cancer lesion on the original CT report were included.
  • Two board-certified abdominal radiologists independently reviewed prediagnostic CTs, classifying pancreatic parenchyma and duct findings and resolving disagreements by consensus.
  • Main analysis was descriptive, with interobserver agreement assessed using Cohen’s kappa; no control group analysis was performed.

## Limitations

  • The paper states this was a retrospective analysis with a small sample from a single center, so results may not reflect other institutions.
  • The authors note that only patients who had CT before diagnosis were included, so the study cannot represent all pancreatic cancers detected incidentally.
  • The paper says an appropriate control group could not be selected, so statistical analysis could not be performed; additionally, the CT-to-diagnosis interval varied from 1.9 to 12 months, making the prediagnostic CT findings less refined.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.21037/jgo-22-863

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 A case of mass-like lesion without pancreatic duct dilatation on the prediagnostic CT image. A 78-year-old man presented with fever and underwent chest and abdominal CT. He was diagnosed with pneumonia based on the chest CT findings and treated in the department of pulmonology. (A) On a retrospective review, a suspected 1.2-cm small hypoattenuating mass lesion (white arrow) without pancreatic duct dilatation was observed in the pancreatic head. (B) Five months later, the patient was admitted for abdominal pain and fever. The abdominal CT shows a 3-cm hypoattenuating mass (white arrow) in the pancreatic head, mild parenchymal swelling, and mild main pancreatic duct dilatation (black arrow). He was histologically confirmed as having pancreatic adenocarcinoma. CT, computed tomography.
Figure 1 A case of mass-like lesion without pancreatic duct dilatation on the prediagnostic CT image. A 78-year-old man presented with fever and underwent chest and abdominal CT. He was diagnosed with pneumonia based on the chest CT findings and treated in the department of pulmonology. (A) On a retrospective review, a suspected 1.2-cm small hypoattenuating mass lesion (white arrow) without pancreatic duct dilatation was observed in the pancreatic head. (B) Five months later, the patient was admitted for abdominal pain and fever. The abdominal CT shows a 3-cm hypoattenuating mass (white arrow) in the pancreatic head, mild parenchymal swelling, and mild main pancreatic duct dilatation (black arrow). He was histologically confirmed as having pancreatic adenocarcinoma. CT, computed tomography.CC BY-NC-ND · PubMed Central
Figure 2 A case of distal pancreatic atrophy without pancreatic duct dilatation on the prediagnostic CT image. A 78-year-old woman underwent regular chest CT follow-ups at the department of thoracic surgery after lung cancer surgery. (A) The chest CT included the pancreas in the early arterial phase. In the imaging analysis by the reviewer, distal parenchymal atrophy (white arrows) was detected at the tail of pancreas, but it was not accompanied by focal pancreatic duct dilatation and an identifiable mass. (B) Six months later, abdominal CT follow-up examination was conducted without any symptoms. A 1.2-cm hypoattenuating mass (white arrow) with distal parenchymal atrophy (black arrows) was suspected. The patient was diagnosed with pancreatic cancer and underwent distal pancreatectomy. She was histologically confirmed as having pancreatic adenocarcinoma. CT, computed tomography.
Figure 2 A case of distal pancreatic atrophy without pancreatic duct dilatation on the prediagnostic CT image. A 78-year-old woman underwent regular chest CT follow-ups at the department of thoracic surgery after lung cancer surgery. (A) The chest CT included the pancreas in the early arterial phase. In the imaging analysis by the reviewer, distal parenchymal atrophy (white arrows) was detected at the tail of pancreas, but it was not accompanied by focal pancreatic duct dilatation and an identifiable mass. (B) Six months later, abdominal CT follow-up examination was conducted without any symptoms. A 1.2-cm hypoattenuating mass (white arrow) with distal parenchymal atrophy (black arrows) was suspected. The patient was diagnosed with pancreatic cancer and underwent distal pancreatectomy. She was histologically confirmed as having pancreatic adenocarcinoma. CT, computed tomography.CC BY-NC-ND · PubMed Central
Figure 3 A case of focal pancreatic duct dilatation without an identifiable mass on the prediagnostic computed tomography (CT) image. A 76-year-old woman underwent regular abdominal CT follow-ups at the department of oncology after gastric cancer surgery. (A) In the imaging analysis by the reviewer, mild focal pancreatic duct dilatation (white arrows) without an identifiable mass (black arrow) was detected at the tail of the pancreas. (B) Ten months later, CT follow-up examination was conducted without any symptoms. An ill-defined hypoattenuating mass (white arrow) of approximately 3 cm with distal pancreatic duct dilatation (black arrow) was detected. The patient was diagnosed with pancreatic cancer and underwent distal pancreatectomy. She was histologically confirmed as having pancreatic adenocarcinoma.
Figure 3 A case of focal pancreatic duct dilatation without an identifiable mass on the prediagnostic computed tomography (CT) image. A 76-year-old woman underwent regular abdominal CT follow-ups at the department of oncology after gastric cancer surgery. (A) In the imaging analysis by the reviewer, mild focal pancreatic duct dilatation (white arrows) without an identifiable mass (black arrow) was detected at the tail of the pancreas. (B) Ten months later, CT follow-up examination was conducted without any symptoms. An ill-defined hypoattenuating mass (white arrow) of approximately 3 cm with distal pancreatic duct dilatation (black arrow) was detected. The patient was diagnosed with pancreatic cancer and underwent distal pancreatectomy. She was histologically confirmed as having pancreatic adenocarcinoma.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

8 Valid · 0 Not valid · 19 Not checked · 43 Own results and interpretations

39 more claims

Create a free account to see all 70 claims and to verify the 2 references still open.

See all claims — free account
  • Probably not a substantial claim. 16
  • It may state two separate claims as one. 15

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 41 references

Cited by

See all 10

Metadata

Authors
Park, B. K., Koh, H. D., Won, S. Y., Cho, Y. S., Seo, J. H., An, C., & Park, S.
Affiliations
National Health Insurance Service Ilsan Hospital (KR)
Corresponding author
Park, Sumi
Venue
Journal of Gastrointestinal Oncology
Published
2023-04
Volume
14
Issue
2
Pages
1008-1018
ISSN
  • 2078-6891 (ISSN-L)
  • 2219-679X
OpenAlex
W4360985647
Cited by
10
References
46
Citations by year
2026: 3 · 2025: 2 · 2024: 4 · 2023: 1
FWCI
1.21
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Journal of Gastrointestinal Oncology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • National Health Insurance Service
  • NATIONAL HEALTH INSURANCE SERVICE ILSANHOSPITAL
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
Keywords
pancreatic cancer, early diagnosis, incidental finding, contrast-enhanced CT

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer. https://app.cochat.ai/papers/10.21037/jgo-22-863
The paper
Park, B. K., Koh, H. D., Won, S. Y., Cho, Y. S., Seo, J. H., An, C., & Park, S. (2023). Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer. Journal of Gastrointestinal Oncology. https://doi.org/10.21037/jgo-22-863

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.